The fate of fungal periprosthetic joint infection after total knee arthroplasty
Authors:
- 5 August 2023
- journal article
- research article
- Published by Springer Nature in International Orthopaedics
- Vol. 47 (11) , 2727-2735
Abstract
Purpose To demonstrate the clinical outcomes of patients with fungal periprosthetic joint infections (PJIs) after two-stage exchange arthroplasty combined with antifungal therapy. Methods We retrospectively reviewed the outcomes of 41 patients with fungal PJIs after primary total knee arthroplasty (TKA) in a single centre from January 1999 to October 2017. During the first stage of resection arthroplasty, antifungal-impregnated cement spacers (AICSs) were implanted in all patients. After systemic antifungal treatment during the interval between the two surgeries, delayed reimplantation as part of a two-stage exchange protocol was performed when patients were clinically stable. We defined treatment success as a well-functioning arthroplasty without any signs of PJI after a minimum follow-up of two years without antimicrobial suppression. Successful treatment was confirmed by repeat negative cultures as well as a return of inflammatory markers to normal levels. Results The treatment success rate was 63.4% at the final follow-up. Thirty-six of 41 patients (87.8%) met the criteria for second-stage revision after confirmation of complete infection control. The mean prosthesis-free interval was 6.6 months (range, 2.0–30.0 months). During follow-up after two-stage exchange arthroplasty, ten patients (27.7% of 36 patients) unfortunately experienced recurrence or relapse of infection after an average of 31.3 months (range, 2.7–135.6 months). The rate of survivorship free from reinfection was 94.4% at six months, 84.8% at one year, and 73.6% at two years. Cox proportional hazard regression analysis demonstrated that the prosthesis-free interval (HR = 1.016, p = 0.037) and mean length of antifungal treatment (HR = 0.226, p = 0.046) were potential risk factors for failure. Conclusion Fungal PJIs led to devastating clinical outcomes despite even two-stage revision arthroplasty with the use of AICSs and antifungal medications.Keywords
This publication has 37 references indexed in Scilit:
- Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infectionMycoses, 2012
- Fungal peri-prosthetic joint infection after primary total knee replacementThe Journal of Bone and Joint Surgery. British volume, 2012
- Fungal Periprosthetic Hip and Knee Joint InfectionsThe Journal of Arthroplasty, 2012
- New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection SocietyClinical Orthopaedics and Related Research, 2011
- Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral‐oral fluconazole and amphotericin B‐loaded cement spacerKnee Surgery, Sports Traumatology, Arthroscopy, 2010
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Periprosthetic Joint Infection: The Incidence, Timing, and Predisposing FactorsClinical Orthopaedics and Related Research, 2008
- Epidemiology of Total Knee Replacement in the United States Medicare PopulationJournal of Bone and Joint Surgery, 2005
- Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the LiteratureClinical Infectious Diseases, 2002
- Candida albicans Prosthetic Arthritis Treated with Fluconazole AloneJournal of Infection, 2001